Abstract:Obej ctive Abnormal proliferation of T cells plays an important role in the development of autoimmune diseases. The article aimed to study the inhibitory effect of small molecule compound BD691 on T cell proliferation and its mechanism. Methods Human peripheral blood T-lymphocytes were isolated and purified by the immunomagnetic microbeads,then T cells were ac-tivated with anti-CD3/CD28 mAbs or alloantigen.The inhibitory effect of BD691 on activated T cell proliferation, the cytotoxic effect BD891 on resting T cells and the expression of activated T cells marker CD25 were measured by flow cytometry.Furthermore, ELISA was used to detect the secretion of cytokines associated with T cell differentiation. Results BD691 significantly inhibited the prolif-eration of T cells being stimulated by anti-CD3/CD28 mAb or alloantigen in a dose-dependent manner, and IC50 values are (8.5 ± 1.5)μmol/L and (7.2 ±1.3)μmol/L, respectively.However, BD691 had no obvious cytotoxic effects on resting T cells and periph-eral blood mononuclear cells, even at a high concentration ( up to 100μmol/L) .In T cells which were not activated by anti-CD3/CD28 mAb, the percentage of CD25+T cells is only 1.6%of the total cells, while the number increased to 68% after activating treatment.Mean-while, in T cells which were activated by 0, 3.3, 10, 30μmol/L BD691, no obvious change of CD25 expression were observed, while immunosuppressant FK506 (0.1μmol/L) significantly decreased the expression of CD25 +T cells (14.9%).In unactivated T cells, 95.6%cells were at G0/G1 phase, while after activation, the percentage of cells at G0/G1 phase reduced to 57.7%.In addition, BD691 inhibited the secretion of IFN-γ, IL-6 and IL-17 in activated T cells, but had no effects on the secretion of IL-2, IL-4 and IL-10. Co nclusion BD691 exerts no effects on T cell activation, but it inhibits T cell proliferation by inducing T cell cycling arrest at G0/G1 phase.Moreover, BD691 inhibits the secretion of key cytokines (such as IFN-γ, IL-6, IL-17) closely related to the differ-entiation of Th1 and Th17 cells.The results suggest that BD 691 is a potential lead compound to develop a new immunosuppressant for the inhibition of abnormal proliferation and differentiation of T cells.

The prokaryotic sHLA-G1 refolded in vitro inhibits T cell proliferation in mixed lymphocytes culture

[Immune Tolerance Inducing Effects of Soluble Human Leucocyte Antigen G1 on Natural Killer Cells and T Cells].

Leukemia: Derived Heat Shock Protein Gp96-Peptide Complex Contribution to T Cell and Dendritic Cell Activation

Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.

Interactions Between Shla-G1 and Its Receptors ILT2, and KIR2DL4 on NK-92 Cells

Effects of membrane associated HLA-G1 on inducing human anti-murine cytotoxic T lymphocytes and xenogeneic cytotoxic response

Refolding and identification of soluble HLA-G1-peptide complex in vitro

In Vitro Study on T Cell Proliferation Inhibited by TGF-β and Its Mechanism

Peptide-dependent inhibition of alloreactive T-cell response by soluble divalent HLA-A2/IgG molecule in vitro.

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.

[The Effects of IGHG1 on the Proliferation and Apoptosis of Human Acute Myeloid Leukemia THP-1 Cells].

The effect of altered CⅡ peptides on HLA-DRB1 restricted T cell responses

Effect of FTY720 on Lymphocytes Proliferation and Apoptosis of in Vitro Mixed Lymphocytes Reaction

Influences of MMF on the presentation functions of in vitro cultured dendritic cells

Inhibitory effect of small molecule compound BD691 on activated T cell proliferation and its mechanism

Soluble Hla-G Inhibits Myeloid Dendritic Cell Function In Hiv-1 Infection By Interacting With Leukocyte Immunoglobulin-Like Receptor B2

HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation

In vitro anti-tumor effect of invariant chain silenced dendritic cells

In Vitro Expression and Purification of Heavy Chain and Β2m of Soluble HLA-G1

[Effects of Humanized Recombinant CD25 Monoclonal Antibody on Activation and Proliferation of T Lymphocytes].